Drug intelligence / Profile preview

Qiangxin Jieyu decoction

Development stage: Preclinical
Lead developer: Jiangsu Province Hospital on Integration of Chinese and Western Medicine
Administration: Oral

Overview

Qiangxin Jieyu decoction is a traditional Chinese medicine (TCM) herbal formula developed by the Jiangsu Province Hospital on Integration of Chinese and Western Medicine. It is formulated as oral granules and is being evaluated for the treatment of chronic heart failure complicated by depressive symptoms. The decoction is designed to improve cardiac function and alleviate depressive symptoms, potentially by modulating blood serotonin (5-hydroxytryptamine) levels and reducing oxidative stress and inflammatory pathways.

Other names: Qiangxin JieyuQiangxin Jieyu decoction granulesQiangxin Jieyu formulaQiangxin Jieyu prescription强心解郁方强心解郁汤强心解郁颗粒

Beyond the preview

Go deeper on Qiangxin Jieyu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiangxin Jieyu decoction.

Explore the full profile